Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond

Gennaro Gadaleta-Caldarola, Rosa Divella, Antonio Mazzocca, Stefania Infusino, Emanuela Ferraro, Gianfranco Filippelli, Antonella Daniele, Carlo Sabbà, Ines Abbate, Mario Brandi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2263-2266
Number of pages4
JournalFuture Oncology
Issue number16
Publication statusPublished - Aug 1 2015


  • HCC
  • multikinase inhibitors
  • RAS/RAF/MEK/ERK pathway
  • sorafenib

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this